Automated antinuclear immunofluorescence antibody screening: A comparative study of six computer-aided diagnostic systems

Autoimmunity Reviews

Volumn 13, Issue 3, 2014, Pages 292-298

  Bizzaro, Nicola ^a   Antico, Antonio ^b   Platzgummer, Stefan ^b   Tonutti, Elio ^c   Bassetti, Danila ^d   Pesente, Fiorenza ^a   Tozzoli, Renato ^e   Tampoia, Marilina ^f   Villalta, Danilo ^e  

^a Department of Emergency and Cardiology   (Italy)

^b Ospedale Civile   (Italy)

^c SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^d SANTA CHIARA HOSPITAL   (Italy)

^e S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^f UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

Author keywords

Anti nuclear antibodies; Autoimmune rheumatic diseases; Automation; Computer aided systems; Immunofluorescence

Indexed keywords

ANTINUCLEAR ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY SCREENING; AUTOIMMUNE DISEASE; BLADDER CANCER; CENTROMERE; EPSTEIN BARR VIRUS INFECTION; FIBROMYALGIA; HEPATITIS C; HUMAN; IMMUNOFLUORESCENCE; LIGHT INTENSITY; NEPHROTIC SYNDROME; NOSE DISEASE; PATTERN RECOGNITION; PRIMARY BILIARY CIRRHOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; URTICARIA;

ANTI-NUCLEAR ANTIBODIES; AUTOIMMUNE RHEUMATIC DISEASES; AUTOMATION; COMPUTER-AIDED SYSTEMS; IMMUNOFLUORESCENCE;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOMATION, LABORATORY; FALSE NEGATIVE REACTIONS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 84891738740     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.10.015     Document Type: Review

References (29)

1. Fritzler M.J. Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent. Autoimmun Highlights 2012, 3:51-58.
2. Tozzoli R., Bizzaro N., Tonutti E., Villalta D., Bassetti D., Manoni F., et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002, 117:316-324.
3. Bizzaro N., Wiik A. Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol 2004, 22:349-355.
4. Wiik A.S., Bizzaro N. Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases. Autoimmun Highlights 2012, 3:35-49.
5. Tozzoli R., Bonaguri C., Melegari A., Antico A., Bassetti D., Bizzaro N. Current state of diagnostic technologies in the autoimmunology laboratory. Clin Chem Lab Med 2013, 51:129-138.
6. Solomon D.H., Kavanaugh A.J., Schur P.H., the ACR ad hoc Committee on Immunologic Testing Guidelines Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002, 47:434-444.
7. Almeida Gonzales D., Cabrera de Leon A., del Cristo Rodriguez Perez M., Brito Diaz B., Gonzalez Hernandez A., Garcia Garcia A., et al. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens. J Immunol Methods 2010, 360:89-95.
8. Fritzler M.J. The antinuclear antibody test: last or lasting gasp?. Arthritis Rheum 2011, 63:19-22.
9. Op De Beéck K., Vermeersch P., Verschueren P., Westhovens R., Mariën G., Blockmans D., et al. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev 2012, 12:137-143.
10. Copple S.S., Rashelles Giles S., Jaskowski T.D., Gardiner A.E., Wilson A.M., Hill H.R. Screening for IgG antinuclear antibodies by HEp-2 indirect fluorescent antibody assays and the need for standardization. Am J Clin Pathol 2012, 137:825-830.
11. Bizzaro N., Tozzoli R., Tonutti E., Piazza A., Manoni F., Ghirardello A., et al. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with biomedical industry. J Immunol Methods 1998, 219:99-107.
12. Boland M.V., Murphy R.F. A neural network c1assifier capable of recognizing the patterns of all major subcellular structures in fluorescence microscope images of HeLa cells. Bioinformatics 2001, 17:1213-1223.
13. Nattkemper T.W., Twellmann T., Ritter H., Schubert W. Human vs. machine: evaluation of fluorescence micrographs. Comput Biol Med 2003, 33:31-43.
14. Sack U., Knoechner S., Warschkau H., Pigia U., Emmrich F., Kamprad M. Computer-assisted classification of HEp-2 immunofluorescence patterns in autoimmune diagnostics. Autoimmun Rev 2003, 2:298-304.
15. Hu V., Murphy R.F. Automated interpretation of subcellular patterns from immunofluorescence microscopy. J Immunol Methods 2004, 290:93-105.
16. Glory E., Murphy R.F. Automated subcellular location determination and high-throughput microscopy. Dev Cell 2007, 12:7-16.
17. Rigon A., Soda P., Zennaro D., lannello G., Afeltra A. Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose. Cytometry B 2007, 72B:472-477.
18. Tozzoli R., Antico A., Porcelli B., Bassetti D. Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory. Autoimmun Highlights 2012, 3:59-65.
19. Hiemann R., Buttner T., Krieger T., Roggenbuck D., Sack U., Conrad K. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 2009, 9:17-22.
20. Egerer K., Roggenbuck D., Hiemann R., Weyer M.G., Buttner T., Radau B., et al. Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther 2010, 12:R40.
21. Rigon A., Buzzulini F., Soda P., Onofri L., Arcarese L., lannello G., et al. Novel opportunities in automated classification of antinuclear antibodies on HEp-2 cells. Autoimmun Rev 2011, 10:647-652.
22. Voigt J., Krause C., Rohwader E., Saschenbrecker S., Hahn M., Danckwardt M., et al. Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clin Dev Immunol 2012, 651058.
23. Op De Beéck K., Vermeersch P., Verschueren P., Westhovens R., Mariën G., Blockmans D., et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011, 10:801-808.
24. Kivity S., Gilburd B., Agmon-Levin N., Carrasco M.G., Tzafrir V., Sofer V., et al. A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol 2012, 31:503-509.
25. Melegari A., Bonaguri C., Russo A., Luisita B., Trenti T., Lippi G. A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev 2012, 11:713-716.
26. Bossuyt X., Cooreman S., De Baere H., Verschueren P., Westhovens R., Blockmans D., et al. Detection of antinuclear antibodies by automated indirect immunofluorescence analysis. Clin Chim Acta 2012, 415C:101-106.
27. Bonroy C., Verfaillie C., Smith V., Persijn L., De Witte E., De Kayser F., et al. Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative far visual microscope interpretation. Clin Chem Lab Med 2013, 51:1771-1779.
28. Wiik A., Høier-Madsen M., Forslid J., Charles P., Meyrowitsch J. Antinuclear antibodies. A contemporary nomenclature using HEp-2 cells. J Autoimmun 2010, 35:276-290.
29. Vermeersch P., Bossuyt X. Prevalence and clinical significance of rare antinuclear antibody patterns. Autoimmun Rev 2013, 12:998-1003.